Trials / Terminated
TerminatedNCT02436356
New Tools for Assessing Fracture Risk
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to determine whether two new, non-X-ray techniques can discriminate between high-energy fractures of normal bone (trauma) and low-energy fractures (fragility) of osteoporotic bone. The current gold-standard for assessing fracture risk areal bone mineral density (aBMD) by dual energy X-ray absorptiometry (DXA) is not particularly effective at identifying individuals who are at risk of suffering a fracture. Yet, there is a growing population of diabetics and elderly individuals prone to fractures. In effect, the age-related and diabetes-related increase in fracture risk is independent of a person's aBMD. These findings stress the urgency in developing diagnostic tools that can improve fracture risk prediction so that patients can be treated with the appropriate anti-fracture therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Osteoprobe-Reference Point Indentation (RPI) | Diagnostic tool used for bone indentation to measure the ability of the tissue to resist microindentation (bone mineral strength). |
| RADIATION | Dual-energy X-ray absorptiometry (DXA) Scans | Assessment of Fracture Risk |
| RADIATION | MRI | Determines bound water and pore water of bone. |
Timeline
- Start date
- 2015-06-30
- Primary completion
- 2018-05-23
- Completion
- 2018-11-08
- First posted
- 2015-05-06
- Last updated
- 2020-11-02
- Results posted
- 2020-10-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02436356. Inclusion in this directory is not an endorsement.